The average life expectancy of people diagnosed with dementia ranges from 9 years at age 60 to 4.5 years at age 85 for women ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Hosted on MSN14h
Finally, an accurate blood test for Alzheimer’s at its earliest stages could be on horizonWhen Dr. Alois Alzheimer first identified the disease that would bear his name in 1906, he could only confirm his diagnosis ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer’s disease in older adults.
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
A study has found cardiovascular conditions such as high blood pressure and diabetes, which are known to contribute to brain blood vessel damage in younger populations, not to be associated with an ...
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
Recent studies implicate the immune system and a herpes virus as potential contributors to development of the disease.
Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback